Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation.
I David MontaniBarbara GirerdXavier JaïsPierantonio LavenezianaEdmund M T LauAmir BouchachiSébastien HascoetSven GüntherLaurent GodinasFlorence ParentChristophe GuignabertAntoine BeurnierDenis ChemlaPhilippe HervéMélanie EyriesFlorent SoubrierGérald SimonneauOlivier SitbonLaurent SavaleMarc HumbertPublished in: The European respiratory journal (2021)
Asymptomatic BMPR2 mutation carriers have a significant risk of developing incident PAH. International multicentre studies are needed to confirm that refined multimodal screening programmes with regular follow-up allow early detection of PAH.